Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2005
03/15/2005CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists
03/10/2005WO2005021776A2 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF
03/10/2005WO2005021546A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
03/10/2005WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative
03/10/2005WO2005021532A1 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
03/10/2005WO2005021513A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
03/10/2005WO2005021512A1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
03/10/2005WO2005021509A1 Quinoline derivatives as neutrophil elastase inhibitors and their use
03/10/2005WO2005021508A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
03/10/2005WO2005021008A1 Iontophoresis-administered composition
03/10/2005WO2005020982A2 Using selective antagonists of persistent sodium current to treat neurological disorders and pain
03/10/2005WO2005009421A8 The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity
03/10/2005WO2004041794A8 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
03/10/2005WO2004012733A9 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003104260A3 Pharmaceutical formulation
03/10/2005WO2003103475A3 Prevention and reduction of blood loss
03/10/2005WO2003037167A9 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
03/10/2005WO2003007875A9 Compounds with analgesic, antipyretic and/or anti-inflammatory activity
03/10/2005US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/10/2005US20050054833 Immunoglobulin fusion for use in treatment and prevention of asthma, food allergies, sinus inflammation and vision defects
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054735 6-Methoxy-2-naphthylacetic acid prodrugs
03/10/2005US20050054728 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054704 Derivatives of [6,7-dihydro-5H- Imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
03/10/2005US20050054700 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
03/10/2005US20050054670 Angiogenesis inhibitors; anticancer agents; antiinflammatry agents
03/10/2005US20050054668 Antagonists of MCP-1 function and methods of use thereof
03/10/2005US20050054653 Pteridine derivatives, method of producing them and their application
03/10/2005US20050054622 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound
03/10/2005US20050054614 Methods of inhibiting leukocyte accumulation
03/10/2005US20050054593 New drug
03/10/2005US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050054577 Irritable bowel disorders; controlling permeability of intestine tissue ; anticholinergic agent
03/10/2005US20050054566 Calcium-influx inhibitory factor and method of isolation thereof
03/10/2005US20050054564 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
03/10/2005US20050054563 Transgenic bacteria host cell can be used for screening antibiotics , herbicides; genetic engineering; therapy for bone disorders; antiarthritic agents
03/10/2005US20050054556 Therapy for rheumatic disease; mixture of antiinflammatory agent and albumin hydrolyzates
03/10/2005US20050054095 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050053604 Administering avian polyclonal antibodies to treat inflammatory bowel disease in birds or humans and for colitis including Crohn's disease
03/10/2005US20050053601 Protein with amino acid sequences for central nervous systems in mammals
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005CA2539953A1 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
03/10/2005CA2537088A1 Using selective antagonists of persistent sodium current to treat neurological disorders and pain
03/10/2005CA2537060A1 Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
03/10/2005CA2531506A1 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
03/09/2005EP1512679A1 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them
03/09/2005EP1512415A1 Decoy composition for treating and preventing inflammatory disease
03/09/2005EP1512400A1 Treatment of neurodegenerative diseases
03/09/2005EP1512397A1 O-substituted hydroxyaryl derivatives
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511853A2 Regulation of novel human asparagine-hydroxylases
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511757A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
03/09/2005EP1511749A1 Novel interleukin-1beta converting enzyme inhibitors
03/09/2005EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors
03/09/2005EP1511742A1 Kinase inhibitors
03/09/2005EP1511740A1 Phenyl-thiophene type vitamin d receptor modulators
03/09/2005EP1511737A1 Aryloximes
03/09/2005EP1511736A1 Therapeutic molecules and methods-1
03/09/2005EP1511734A2 Compounds, compositions, and methods
03/09/2005EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511718A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
03/09/2005EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/09/2005EP1511516A1 Topically applicable pharmaceutical preparation
03/09/2005EP1511502A2 Probiotic therapies using lactobacillus reuteri
03/09/2005EP1511499A2 Immunomodulatory compounds and methods of use thereof
03/09/2005EP1511491A1 Derivatives of azepine and thiazepan as interleukin converting enzyme inhibitors
03/09/2005EP1511488A2 Human adam-10 inhibitors
03/09/2005EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1303261B1 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
03/09/2005EP1272499B1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
03/09/2005EP1140112B1 Etherlysophospholipids for the treatment of chronic inflammatory diseases
03/09/2005EP1137429B1 Cherry extracts for inhibiting cyclooxygenase enzymes
03/09/2005EP1126849B1 Heterocyclic potassium channel inhibitors
03/09/2005EP0944645B1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME
03/09/2005EP0831847B1 Method of synthesis of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions
03/09/2005EP0817627B1 Protein kinase c inhibitors
03/09/2005EP0673241B1 Use of a free radical quenching liposomal composition for the manufacture of a medicament for the treatment of inflammatory conditions
03/09/2005CN1592747A Diazabicyclo alkane derivatives with NK1 antagonistic activity
03/09/2005CN1592746A LFA-1 antagonist compounds
03/09/2005CN1592704A Adsorbents and uses thereof
03/09/2005CN1592681A System, method and device for mfg. dosage forms
03/09/2005CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination
03/09/2005CN1592618A Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
03/09/2005CN1590375A TNF-alpha prodn. inhibitors
03/09/2005CN1590374A TNF-alpha prodn. inhibitors
03/09/2005CN1590373A Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
03/09/2005CN1589906A New oral formulation for 5-HT4 agonists or antagonists
03/09/2005CN1589905A Medical composition for treating desmosis and its use
03/09/2005CN1589903A Methods for amyloid removal using anti-amyloid antibodies
03/09/2005CN1589900A Medical health protection use of globe fish glue
03/09/2005CN1589897A Biological immune preparation for treating dairy cattle clinical mamitis and its manufacturing method
03/09/2005CN1589884A External use Chinese medicinal lotion for treating gynecopathy inflammation
1 ... 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 ... 1272